# XACDURO (COPACKAGED)
> **NDA216974** · New Drug Application · Sponsor: ENTASIS THERAP · Approved 2023-05-23
## Drug
- **FDA Application Number:** NDA216974
- **Application type:** New Drug Application
- **Brand name:** XACDURO (COPACKAGED)
- **Generic name:** SULBACTAM AND DURLOBACTAM
- **Active ingredients:** DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ENTASIS THERAP
- **Manufacturer:** La Jolla Pharmaceutical Company
- **First approval:** 2023-05-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216974)
---
*AI Analytics · CC0 1.0*